European Commission approves Roche's Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
- Details
- Category: Roche
Molecular 'super-glue' shows promise of cancer drug discovery platform
- Details
- Category: Research
Accelerating how new drugs are made with machine learning
- Details
- Category: Research
Predicting how molecules will react is vital for the discovery and manufacture of new pharmaceuticals, but historically this has been a trial-and-error process, and the reactions often fail.
Bayer's AskBio initiates Phase II GenePHIT trial in Congestive Heart Failure (CHF)
- Details
- Category: Bayer
mRNA technology could be possible treatment for rare diseases
- Details
- Category: Research
The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.
TIVDAK® supplemental Biologics License Application accepted for Priority Review by FDA for patients with recurrent or metastatic cervical cancer
- Details
- Category: Pfizer
Smart skin bacteria are able to secrete and produce molecules to treat acne
- Details
- Category: Research
Creating novel amino acid nanoparticles with enhanced anticancer activity
- Details
- Category: Research
Major breakthrough unveils immune system's guardian: IKAROS
- Details
- Category: Research
This disruptive research, led by the eminent Professor Nicholas Huntington of Monash University's Biomedicine Discovery Institute, is poised to reshape our comprehension of gene control networks and its impact on everything from eye colour to cancer susceptibility and design of novel therapies.
AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson's disease meets primary endpoint
- Details
- Category: Bayer